Your browser doesn't support javascript.
loading
Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency.
Vavassori, Stefano; Chou, Janet; Faletti, Laura Eva; Haunerdinger, Veronika; Opitz, Lennart; Joset, Pascal; Fraser, Christopher J; Prader, Seraina; Gao, Xianfei; Schuch, Luise A; Wagner, Matias; Hoefele, Julia; Maccari, Maria Elena; Zhu, Ying; Elakis, George; Gabbett, Michael T; Forstner, Maria; Omran, Heymut; Kaiser, Thomas; Kessler, Christina; Olbrich, Heike; Frosk, Patrick; Almutairi, Abduarahman; Platt, Craig D; Elkins, Megan; Weeks, Sabrina; Rubin, Tamar; Planas, Raquel; Marchetti, Tommaso; Koovely, Danil; Klämbt, Verena; Soliman, Neveen A; von Hardenberg, Sandra; Klemann, Christian; Baumann, Ulrich; Lenz, Dominic; Klein-Franke, Andreas; Schwemmle, Martin; Huber, Michael; Sturm, Ekkehard; Hartleif, Steffen; Häffner, Karsten; Gimpel, Charlotte; Brotschi, Barbara; Laube, Guido; Güngör, Tayfun; Buckley, Michael F; Kottke, Raimund; Staufner, Christian; Hildebrandt, Friedhelm.
Afiliação
  • Vavassori S; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Chou J; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Faletti LE; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Haunerdinger V; Division of Stem Cell Transplantation and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Opitz L; Functional Genomics Center Zürich, University of Zurich, Zurich, Switzerland.
  • Joset P; Institute of Medical Genetics, University of Zurich, Schlieren, Switzerland.
  • Fraser CJ; Queensland Children's Hospital, South Brisbane, Australia.
  • Prader S; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Gao X; Division of Pediatric Pneumology, Dr. von Hauner Children's Hospital, University Hospital Munich, German Center for Lung Research (DZL), Munich, Germany.
  • Schuch LA; Division of Pediatric Pneumology, Dr. von Hauner Children's Hospital, University Hospital Munich, German Center for Lung Research (DZL), Munich, Germany.
  • Wagner M; Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
  • Hoefele J; Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
  • Maccari ME; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Zhu Y; New South Wales Health Pathology Genomics, Prince of Wales Hospital, Sydney, Australia.
  • Elakis G; New South Wales Health Pathology Genomics, Prince of Wales Hospital, Sydney, Australia.
  • Gabbett MT; Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia.
  • Forstner M; Division of Pediatric Pneumology, Dr. von Hauner Children's Hospital, University Hospital Munich, German Center for Lung Research (DZL), Munich, Germany.
  • Omran H; Clinic for General Pediatrics, University Hospital Münster, Münster, Germany.
  • Kaiser T; Clinic for General Pediatrics, University Hospital Münster, Münster, Germany.
  • Kessler C; Clinic for General Pediatrics, University Hospital Münster, Münster, Germany.
  • Olbrich H; Clinic for General Pediatrics, University Hospital Münster, Münster, Germany.
  • Frosk P; Division of Clinical Immunology and Allergy, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada.
  • Almutairi A; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass; Department of Pediatrics, Security Forces Hospital, Riyadh, Saudi Arabia.
  • Platt CD; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Elkins M; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Weeks S; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Rubin T; Division of Pediatric Clinical Immunology and Allergy, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada.
  • Planas R; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Marchetti T; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Koovely D; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Klämbt V; Division of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
  • Soliman NA; Department of Pediatrics, Center of Pediatric Nephrology and Transplantation, Cairo University, Cairo, Egypt.
  • von Hardenberg S; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Klemann C; Department of Paediatric Pulmonology, Allergy and Neonatology, Hannover Medical School, Hannover, Germany.
  • Baumann U; Department of Paediatric Pulmonology, Allergy and Neonatology, Hannover Medical School, Hannover, Germany.
  • Lenz D; Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Klein-Franke A; Division of Pediatric Hematology and Oncology, Cantonal Hospital Aarau, Aarau, Switzerland.
  • Schwemmle M; Institute of Virology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Huber M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Sturm E; Division of Pediatric Gastroenterology and Hepatology, University Hospital Tübingen, Tübingen, Germany.
  • Hartleif S; Division of Pediatric Gastroenterology and Hepatology, University Hospital Tübingen, Tübingen, Germany.
  • Häffner K; Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Gimpel C; Department of Internal Medicine IV (Nephrology), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Brotschi B; Department of Pediatric and Neonatal Intensive Care, University Children's Hospital Zurich, Zurich, Switzerland.
  • Laube G; Division of Nephrology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Güngör T; Division of Stem Cell Transplantation and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
  • Buckley MF; New South Wales Health Pathology Genomics, Prince of Wales Hospital, Sydney, Australia.
  • Kottke R; Division of Neuroradiology, Department of Diagnostic Imaging and Intervention, University Children's Hospital Zurich, Zurich, Switzerland.
  • Staufner C; Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Hildebrandt F; Division of Nephrology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
J Allergy Clin Immunol ; 148(2): 381-393, 2021 08.
Article em En | MEDLINE | ID: mdl-33872655
BACKGROUND: Recognition of viral nucleic acids is one of the primary triggers for a type I interferon-mediated antiviral immune response. Inborn errors of type I interferon immunity can be associated with increased inflammation and/or increased susceptibility to viral infections as a result of dysbalanced interferon production. NFX1-type zinc finger-containing 1 (ZNFX1) is an interferon-stimulated double-stranded RNA sensor that restricts the replication of RNA viruses in mice. The role of ZNFX1 in the human immune response is not known. OBJECTIVE: We studied 15 patients from 8 families with an autosomal recessive immunodeficiency characterized by severe infections by both RNA and DNA viruses and virally triggered inflammatory episodes with hemophagocytic lymphohistiocytosis-like disease, early-onset seizures, and renal and lung disease. METHODS: Whole exome sequencing was performed on 13 patients from 8 families. We investigated the transcriptome, posttranscriptional regulation of interferon-stimulated genes (ISGs) and predisposition to viral infections in primary cells from patients and controls stimulated with synthetic double-stranded nucleic acids. RESULTS: Deleterious homozygous and compound heterozygous ZNFX1 variants were identified in all 13 patients. Stimulation of patient-derived primary cells with synthetic double-stranded nucleic acids was associated with a deregulated pattern of expression of ISGs and alterations in the half-life of the mRNA of ISGs and also associated with poorer clearance of viral infections by monocytes. CONCLUSION: ZNFX1 is an important regulator of the response to double-stranded nucleic acids stimuli following viral infections. ZNFX1 deficiency predisposes to severe viral infections and a multisystem inflammatory disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viroses / Predisposição Genética para Doença / Sequenciamento do Exoma / Doenças da Imunodeficiência Primária / Antígenos de Neoplasias Tipo de estudo: Clinical_trials Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Viroses / Predisposição Genética para Doença / Sequenciamento do Exoma / Doenças da Imunodeficiência Primária / Antígenos de Neoplasias Tipo de estudo: Clinical_trials Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article